William Plovanic


Canaccord Maintains Buy on MiMedx Group Inc Following Analyst Day

In a research note issued today, Canaccord analyst William Plovanic maintained a Buy rating on shares of MiMedx Group Inc (NASDAQ:MDXG), with a price target of …

EnteroMedics Inc’s (ETRM) Early Commercialization Progress Is ‘Encouraging’: Canaccord

Canaccord analyst William Plovanic weighed in today with an optimistic view on EnteroMedics Inc (NASDAQ:ETRM), following the company’s recent second-quarter results and a presentation at the …

Canaccord Cuts Price Target For EnteroMedics Inc Following $16M Public Offering

In a research report published Tuesday, Canaccord Genuity analyst William Plovanic maintained a Buy rating on shares of EnteroMedics Inc (NASDAQ:ETRM), while reducing the …

Canaccord Genuity Reiterates Buy on EnteroMedics Inc; Here’s Why

Canaccord Genuity’s healthcare analyst William Plovanic weighed in with an optimistic view on EnteroMedics Inc (NASDAQ:ETRM), after the company provided an update regarding the training and …

Canaccord Remains Positive On EnteroMedics Inc Following 4Q14 Update

In a research report released this morning, Canaccord Genuity analyst William Plovanic reiterated a Buy rating on EnteroMedics Inc (NASDAQ:ETRM) with a $4 price target, …

UPDATE: Canaccord Maintains Buy On Enteromedics Following FDA Approval For VBLOC Maestro System

In a research report issued a short while ago, Canaccord Genuity analyst William Plovanic maintained a Buy rating on Enteromedics (NASDAQ:ETRM) with a …

Canaccord Genuity Maintains Buy On Stryker Shares, $84 PT

In a research report issued today, Canaccord Genuity analyst William Plovanic maintained a Buy rating on Stryker Corp (NYSE:SYK) with a price target …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts